Sangamo Therapeutics Inc. (SGMO)
NASDAQ: SGMO
· Real-Time Price · USD
0.58
0.04 (7.41%)
At close: Aug 15, 2025, 3:59 PM
0.59
1.21%
After-hours: Aug 15, 2025, 07:49 PM EDT
Sangamo Therapeutics Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 81.71M | 63.76M | 57.8M | 52.29M | 12.28M | 18.76M | 176.23M | 201.42M | 218.48M | 241.03M | 111.3M | 112.06M | 114.16M | 112.65M | 110.7M | 108.52M | 137.72M | 131.4M |
Cost of Revenue | 4.26M | 6.83M | 9.36M | 10.21M | 19.55M | 21.23M | 22.19M | 22.55M | 14.14M | 12.77M | 12.11M | 11.53M | 70.98M | 128.18M | 181.78M | 231.38M | 214.16M | 195.6M |
Gross Profit | 79.58M | 37.41M | 28.92M | 20.43M | -28.92M | -2.47M | 154.04M | 178.87M | 204.34M | 228.26M | 99.19M | 100.53M | 43.18M | -15.53M | -71.08M | -122.86M | -76.45M | -64.21M |
Operating Income | -62.84M | -82.07M | -103.97M | -140.34M | -257.38M | -343.87M | -157.17M | -150.2M | -98.68M | -20.84M | -201.28M | -185.79M | -179.33M | -182.3M | -183.34M | -186.87M | -142.13M | -131.33M |
Interest Income | 2.99M | 3.63M | 3.78M | 3.1M | 6.49M | 8.26M | 11.1M | 13.29M | 11.54M | 8.74M | 5.45M | 4.11M | 2.34M | 2.34M | 2.34M | 2.87M | 2.87M | 4.8M |
Pretax Income | -63.5M | -79.59M | -98.11M | -134.85M | -248.5M | -333.22M | -262.9M | -254.05M | -204.28M | -126.6M | -191.85M | -177.7M | -172.18M | -176.23M | -177.99M | -181M | -134.66M | -123.48M |
Net Income | -63.31M | -79.45M | -97.94M | -134.84M | -249.68M | -328.05M | -257.83M | -249.51M | -198.5M | -127.17M | -192.28M | -177.8M | -172.33M | -176.33M | -178.29M | -181.39M | -135.26M | -124.02M |
Selling & General & Admin | 40.05M | 43.02M | 44.73M | 47.96M | 50.83M | 54.8M | 61.17M | 64.51M | 66.83M | 65.91M | 62.68M | 62.32M | 60.59M | 61.98M | 63.22M | 64.01M | 65.69M | 67.13M |
Research & Development | 104.5M | 101.64M | 111.52M | 138.55M | 167.91M | 206.73M | 234.06M | 249.53M | 257.56M | 254.53M | 249.9M | 235.52M | 232.9M | 232.97M | 230.82M | 231.38M | 214.16M | 195.6M |
Other Expenses | n/a | -23.05M | 5.52M | 3.14M | -9.15M | 65.25M | 95.25M | 97.63M | 109.92M | 58.57M | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 144.55M | 121.6M | 161.77M | 189.65M | 209.59M | 275.43M | 280.55M | 301.75M | 324.39M | 320.44M | 312.58M | 297.84M | 293.49M | 294.95M | 294.04M | 295.38M | 279.85M | 262.73M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | 113.85M | 113.85M | 113.85M | 116.49M | 3.98M | 3.98M | 3.98M | 1.34M | n/a | n/a | n/a | n/a |
Selling & Marketing Expenses | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 146.73M | 148.01M | 163.95M | 194.81M | 269.66M | 311.28M | 340.62M | 358.84M | 324.39M | 320.44M | 312.58M | 297.84M | 293.49M | 294.95M | 294.04M | 295.38M | 279.85M | 262.73M |
Income Tax Expense | -193K | -146K | -167K | -12K | 1.17M | -5.17M | -5.07M | -4.54M | -5.78M | 565K | 429K | 103K | 159K | 101K | 305K | 480K | 631K | 571K |
Shares Outstanding (Basic) | 256.95M | 220.27M | 210.19M | 208.34M | 203.95M | 180.34M | 177.62M | 177.17M | 174.32M | 168.53M | 164.72M | 156.34M | 148.16M | 146.22M | 145.74M | 145.4M | 143.98M | 143.11M |
Shares Outstanding (Diluted) | 256.95M | 220.27M | 210.19M | 214.32M | 203.95M | 180.34M | 177.62M | 177.17M | 174.32M | 169.18M | 164.72M | 158.04M | 148.16M | 146.22M | 145.74M | 145.4M | 143.98M | 143.11M |
EPS (Basic) | -0.28 | -0.38 | -0.51 | -0.75 | -1.38 | -1.86 | -1.46 | -1.44 | -1.19 | -0.82 | -1.25 | -1.19 | -1.18 | -1.22 | -1.24 | -1.27 | -0.95 | -0.88 |
EPS (Diluted) | -0.28 | -0.39 | -0.52 | -0.75 | -1.38 | -1.86 | -1.47 | -1.45 | -1.2 | -0.83 | -1.25 | -1.19 | -1.18 | -1.22 | -1.24 | -1.27 | -0.95 | -0.88 |
EBITDA | -56.86M | -72.14M | -89.09M | -122.82M | -191.69M | -224.4M | -154.93M | -149.39M | -145.12M | -121.93M | -189.17M | -174.26M | -168.29M | -171.9M | -173.9M | -180.19M | -134.74M | -122.95M |
EBIT | -64.95M | -80.9M | -98.45M | -133.03M | -205.27M | -241.58M | -117.8M | -112.62M | -105.91M | -79.42M | -201.28M | -185.79M | -179.33M | -182.3M | -183.34M | -186.87M | -142.13M | -131.33M |
Depreciation & Amortization | 8.08M | 8.76M | 9.36M | 10.21M | 13.57M | 15.26M | 16.22M | 16.58M | 14.14M | 12.77M | 12.11M | 11.53M | 11.04M | 10.4M | 9.44M | 10.34M | 11.06M | 12.05M |